We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601688:SSEHuatai Securities Co., Ltd. Class A Analysis

Data as of 2026-06-22 - not real-time

CN¥21.29

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Huatai Securities is trading at CNY 21.29, barely below its recent resistance of CNY 21.38 and well above the computed support of CNY 17.92. Technicals show a bullish MACD histogram (+0.21) and an RSI of 68, indicating momentum but edging toward overbought territory. Volume is on an increasing trend, supporting the short‑term price stability. The stock’s beta of 0.53 and a 30‑day volatility of 38% suggest modest market sensitivity coupled with relatively high price swings. Fundamentally, the company delivers a robust revenue growth rate of 45% and a trailing P/E of 11.45, well under the industry average of 16.9. Yet the balance sheet is leveraged, with a debt‑to‑equity ratio of 249% despite a massive cash hoard of CNY 731 billion.
The DCF‑derived fair value of CNY 117.94 implies a substantial undervaluation at current levels. The dividend yield of 2.66% and a modest payout ratio of 28% point to sustainable income for shareholders. Low price‑to‑book (1.13) and forward P/E of 8.79 further reinforce the value case. However, regulatory scrutiny in China’s capital‑markets sector remains a headwind. Given the blend of strong growth, attractive valuation and dividend sustainability, the medium‑term outlook is bullish. Investors should balance the short‑term technical overbought signal against the long‑term upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI approaching overbought
  • Price near resistance level
  • Increasing volume supporting short‑term stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests >400% upside
  • Strong 45% revenue growth and low forward P/E
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued price relative to book and earnings multiples
  • Robust cash position offsetting high leverage
  • Strategic position in China’s capital markets with diversified services

Key Metrics & Analysis

Financial Health

Revenue Growth45.00%
Profit Margin44.41%
P/E Ratio11.4
ROE8.62%
ROA1.71%
Debt/Equity249.40
P/B Ratio1.1
Op. Cash FlowCN¥34.1B
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI68.3
SupportCN¥17.92
ResistanceCN¥21.38
MA 20CN¥19.21
MA 50CN¥19.04
MA 200CN¥20.94
MACDBullish
VolumeIncreasing
Fear & Greed Index90.46

Valuation

Fair ValueCN¥117.94
GradeUndervalued
TypeBlend
Dividend Yield2.66%

Risk Assessment

Beta0.53
Volatility38.42%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.